About Vcanbio Cell & Gene Engineering Corporation
Vcanbio Cell & Gene Engineering Corporation is a company based in Tianjin (China) founded in 2009 by Zhang Yahong.. The company has 2,009 employees as of December 31, 2024. Vcanbio Cell & Gene Engineering Corporation operates in a competitive market with competitors including Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others.
- Headquarter Tianjin, China
- Employees 2009 as on 31 Dec, 2024
- Founders Zhang Yahong
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vcanbio Cell & Gene Engineering Corp., Ltd. Class A
-
Annual Revenue
$215.09 M (USD)-0.29as on Dec 31, 2024
-
Net Profit
$13.75 M (USD)-5.73as on Dec 31, 2024
-
EBITDA
$43.45 M (USD)6.34as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
2009
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vcanbio Cell & Gene Engineering Corporation
Vcanbio Cell & Gene Engineering Corporation is a publicly listed company on the SSE with ticker symbol 600645 in China, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Vcanbio Cell & Gene Engineering Corporation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Vcanbio Cell & Gene Engineering Corporation
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vcanbio Cell Gene Engineering Corporation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vcanbio Cell & Gene Engineering Corporation Comparisons
Competitors of Vcanbio Cell & Gene Engineering Corporation
Vcanbio Cell & Gene Engineering Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| domain | founded_year | HQ Location |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
|
| domain | founded_year | HQ Location |
Transfection Solutions for Healthcare and Life Sciences organizations
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vcanbio Cell & Gene Engineering Corporation
Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corporation
When was Vcanbio Cell & Gene Engineering Corporation founded?
Vcanbio Cell & Gene Engineering Corporation was founded in 2009.
Where is Vcanbio Cell & Gene Engineering Corporation located?
Vcanbio Cell & Gene Engineering Corporation is headquartered in Tianjin, China.
How many employees does Vcanbio Cell & Gene Engineering Corporation have?
As of Dec 31, 2024, the latest employee count at Vcanbio Cell & Gene Engineering Corporation is 2,009.
What is the annual revenue of Vcanbio Cell & Gene Engineering Corporation?
Annual revenue of Vcanbio Cell & Gene Engineering Corporation is $215.09M as on Dec 31, 2024.
What does Vcanbio Cell & Gene Engineering Corporation do?
Founded in 2009 and headquartered in Tianjin, China, Vcanbio Cell Gene Engineering Corporation operates in the biotechnology sector. Stem cell sources are detected and stored, while cells, genes, and cell cultures are prepared and preserved through subsidiaries. Cytokine culture solutions and cosmetics are produced and sold, with business conducted primarily in the domestic market.
Who are the top competitors of Vcanbio Cell & Gene Engineering Corporation?
Vcanbio Cell & Gene Engineering Corporation's top competitors include Abcam, RoosterBio and BioLife Solutions.
Is Vcanbio Cell & Gene Engineering Corporation publicly traded?
Yes, Vcanbio Cell & Gene Engineering Corporation is publicly traded on SSE under the ticker symbol 600645.
What is Vcanbio Cell & Gene Engineering Corporation's ticker symbol?
The ticker symbol of Vcanbio Cell & Gene Engineering Corporation is 600645 on SSE.